Osteonecrosis of the jaw—do bisphosphonates pose a risk?
JP Bilezikian - New England Journal of Medicine, 2006 - Mass Medical Soc
JP Bilezikian
New England Journal of Medicine, 2006•Mass Medical SocOsteonecrosis of the Jaw — Do Bisphosphonates Pose a Risk? | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
Osteonecrosis of the jaw is a potential complication of nitrogen-containing bisphosphonates. Dr. John Bilezikian asks whether there is a relationship between bisphosphonates and osteonecrosis of the jaw and what might explain it.
The New England Journal Of Medicine